BML Investment Partners, L.P.

13D and 13G Filings

13D/G filings: 13D on 9 securities, 13G on 17 securities
CIK: 0001373604
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13D · 9 securities · may seek to influence control
Seer, Inc. 13D SEER · 81578P106	SEER	81578P106	4.7%	2,600,490	13D	11/2/2026 Event 11/2/2026
BML Investment Partners, L.P.			3.9%	2,180,490
Braden M Leonard			4.7%	2,600,490
Adverum Biotechnologies, Inc. 13D/A ADVM · 00773U108	ADVM	00773U108	0%	0	13D/A	12/9/2025 Event 12/9/2025
BML Investment Partners, L.P.			0%	0
Leonard Braden Michael			0%
Astrotech Corporation 13D/A ASTC · 046484309	ASTC	046484309	0%	0	13D/A	10/7/2025 Event 10/3/2025
BML Investment Partners, L.P.			0%	0
Leonard Braden Michael			0%	0
Elevation Oncology, Inc. 13D/A ELEV · 28623U101	ELEV	28623U101	0%	0	13D/A	7/28/2025 Event 7/23/2025
Ikena Oncology, Inc. 13D/A IMA · 45175G207	IMA	45175G207	1.9%	220,832	13D/A	7/28/2025 Event 7/25/2025
BML Investment Partners, L.P.			1.9%	215,832
Leonard Braden Michael			1.9%	220,832
AN2 Therapeutics, Inc. 13D/A ANTX · 037326105	ANTX	037326105	1.4%	427,432	13D/A	6/18/2025 Event 6/17/2025
Ikena Oncology, Inc. 13D IKNA · 45175G108 Amended under CUSIP 45175G207 on 7/28/2025	IKNA	45175G108	8.5%	4,090,102	13D	6/16/2025 Event 6/16/2025
BML Investment Partners, L.P.			8.4%	4,030,102
Leonard Braden Michael			8.5%	4,090,102
ESSA Pharma Inc. 13D EPIX · 29668H708	EPIX	29668H708	9.5%	4,221,546	13D	4/24/2025 Event 4/24/2025
Aadi Bioscience, Inc. 13D/A WHWK · 00032Q104	WHWK	00032Q104	4.98%	2,435,000	13D/A	3/5/2025 Event 3/5/2025
BML Investment Partners, L.P.			4.3%	1,971,137
Leonard Braden Michael			4.98%	2,435,000
Schedule 13G · 17 securities · passive
LENZ Therapeutics, Inc. 13G LENZ · 52635N103	LENZ	52635N103	6.7%	2,110,727	13G	11/4/2026 Event 11/2/2026
Connect Biopharma Holdings Ltd 13G CNTB · G23549101	CNTB	G23549101	6.8%	4,264,400	13G	10/6/2026 Event 9/30/2026
BML Investment Partners, L.P.			6.1%	3,864,400
Braden M Leonard			6.8%	4,264,400
Outset Medical, Inc. 13G/A OM · 690145206	OM	690145206	14.7%	2,764,610	13G/A	10/6/2026 Event 10/2/2026
Oramed Pharmaceuticals Inc. 13G/A ORMP · 68403P203	ORMP	68403P203	2.5%	1,026,269	13G/A	6/29/2026 Event 6/26/2026
BML Investment Partners, L.P.			2.1%	866,269
Leonard Braden Michael			2.5%	1,026,269
enGene Holdings Inc. 13G/A ENGN · 29286M105	ENGN	29286M105	10.0%	6,669,908	13G/A	5/14/2026 Event 5/12/2026
Kezar Life Sciences, Inc. 13G/A KZR · 49372L100	KZR	49372L100	0%	0	13G/A	5/12/2026 Event 5/11/2026
Aclaris Therapeutics, Inc. 13G/A ACRS · 00461U105	ACRS	00461U105	9.9%	13,950,000	13G/A	4/27/2026 Event 4/23/2026
Tilly's, Inc. 13G TLYS · 886885102	TLYS	886885102	9.4%	2,189,186	13G	3/19/2026 Event 3/12/2026
BML Investment Partners, L.P.			9.0%	2,089,186
Leonard Braden Michael			9.4%	2,189,186
Instil Bio, Inc. 13G/A TIL · 45783C101	TIL	45783C101	9.5%	645,600	13G/A	2/9/2026 Event 12/31/2025
PMV Pharmaceuticals, Inc. 13G/A PMVP · 69353Y103	PMVP	69353Y103	9.9%	5,292,000	13G/A	2/9/2026 Event 12/31/2025
Atea Pharmaceuticals, Inc. 13G AVIR · 04683R106	AVIR	04683R106	9.9%	7,810,000	13G	2/9/2026 Event 12/31/2025
BML Investment Partners, L.P.			9.6%	7,490,000
Leonard Braden Michael			9.9%	7,810,000
Athira Pharma Inc. 13G/A ATHA · 04746L104	ATHA	04746L104	0%	0	13G/A	12/18/2025 Event 12/18/2025
BML Investment Partners, L.P.			0%	0
Leonard Braden Michael			0%	0
LAVA Therapeutics N.V. 13G LVTX · N51517105	LVTX	N51517105	7.4%	1,958,110	13G	3/3/2025 Event 2/26/2025
Third Harmonic Bio, Inc. 13G THRD · 88427A107	THRD	88427A107	8.2%	3,724,167	13G	2/14/2025 Event 2/11/2025
Achilles Therapeutics plc 13G/A ACHL · 00449L102	ACHL	00449L102	10.0%	4,100,002	13G/A	2/13/2025 Event 12/31/2024
Climb Bio, Inc. 13G/A CLYM · 28658R106	CLYM	28658R106	0%	0	13G/A	2/13/2025 Event 12/31/2024
BML Investment Partners, L.P.			0%	0
Leonard Braden Michael			0%	0
Tectonic Therapeutic, Inc. 13G/A TECX · 878972108	TECX	878972108	0%	0	13G/A	2/13/2025 Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.